Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX   3:59:41 PM EDT
2.90
-0.07 (-2.36%)
Other Pre-Announcement

Cumberland Pharmaceuticals Reports Q3 2020 Results

Published: 11/10/2020 21:18 GMT
Cumberland Pharmaceuticals Inc (CPIX) - Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update.
Q3 Adjusted Earnings per Share $0.02.
Q3 Revenue $9.3 Million Versus $6.9 Million.
Q3 Loss per Share $0.03.
Cumberland Pharma -to Initially Implement a Soft Launch for Reditrex During Q4, Intends to Follow With a Full Commercial Launch of Brand Next Spring.